PT  - JOURNAL ARTICLE
AU  - Chen, Ying
AU  - Du, Hui
AU  - Bao, Lewen
AU  - Liu, Wenxin
TI  - LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214
AID  - 10.20892/j.issn.2095-3941.2017.0174
DP  - 2018 Aug 01
TA  - Cancer Biology and Medicine
PG  - 238--250
VI  - 15
IP  - 3
4099  - http://www.cancerbiomed.org/content/15/3/238.short
4100  - http://www.cancerbiomed.org/content/15/3/238.full
SO  - Cancer Biol Med2018 Aug 01; 15
AB  - Objective: Emerging evidence indicates that long non-coding RNAs (lncRNAs) are critical in carcinogenesis and progression of ovarian cancer. This study aimed to explore the functions and molecular mechanisms of plasmacytoma variant translocation I (PVT1) in ovarian cancerMethods: PVT1 and miR-214 were detected by qRT-PCR assays in ovarian cancer tissues and cells. The cell proliferation, migration, and invasion abilities were detected by cell functional experiments, respectively. Western blot assay was performed to detect epithelial-mesenchymal transition (EMT) markers. MiR-214 expression regulated by PVT1 was studied by RNA immunoprecipitation (RIP) and chromatin immunoprecipitation (ChIP) assays.Results: The expression of PVT1 was up-regulated in ovarian cancer tissues and cell lines. Elevated PVT1 expression was associated with advanced stage and indicated poor prognosis for ovarian cancer patients. The knockdown of PVT1 impaired SKOV3 cell proliferation, migration, and invasion in vitro. The promotion of ovarian cancer progression by PVT1 involved in regulation of the epithelial-mesenchymal transition process and PVT1 interaction with EZH2 represses miR-214 expression in ovarian cancer cells.Conclusions: PVT1 plays an important role in ovarian cancer tumorigenesis, which might be as a novel diagnostic marker and therapeutic target for ovarian cancer.